Author’s Guidelines

  1. Article types for publication in the Cancer Press (Journal)
     
  2. Editorial and Publishing policies
        2.1 Peer review policy
        2.2 Authorship
        2.3 Acknowledgements
        2.4 Funding
        2.5 Declaration of conflicting interests
        2.6 Publication ethics
        2.7 Open access publication
     
  3. Preparing your manuscript
        3.1 Word processing formats
        3.2 Artwork, figures and other graphics
        3.3 Supplementary material
        3.4 Reference style
        3.5 English language editing services
  1. Submitting your manuscript
        4.1 How to submit your manuscript
        4.2 Corresponding author contact details
     
  2. On acceptance and publication
        5.1 Access to your published article
        5.2 Online First publication
     
  3. Further information

This Journal is a pending member of the Committee on Publication Ethics (COPE)

Please read the guidelines below then visit the Journal’s submission site http://thecancerpress.com/index.php/cp/author/submit/1 to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

Only manuscripts of sufficient quality that meet the aims and scope of the Cancer Press will be reviewed.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

 

 

1. Article types for publication in the Cancer Press (Journal)

The Cancer Press publishes original research and review articles that emphasize following areas: Following areas are focusing scope of Cancer Press.

1.         Cancer diagnosis & prognosis

2.         Cancer treatment and management

3.         Cancer genetics & genomics

4.         Clinical reports on all types of cancer

5.         Cancer prevention

6.         Multidisciplinary research on cancer

7.         Cancer economy

8.         Cancer psychology

9.         Society and cancer

10.       Cancer education.

Types of papers Considered for Publication

All manuscripts must be typewritten in a font size of 12 points, double-spaced (including References, Tables and Figure legends) with wide margins (2.5 cm from all sides) on one side of the paper. The beginning of each new paragraph must clearly be indicated by indentation. All pages should be numbered consecutively at the bottom starting with the title page. Each type of article should has specific requirements as follow:

  • Research Articles: Should be no longer than 20 pages in length including references (but not figures or tables).
  • Short Communications: brief papers (4-5 journal pages or less) making a specific well-documented point.
  • Reviews: (usually 8-10 journal pages excluding references, figures or tables with >100 key references) and Mini-reviews (5-6 journal pages, 3-5 figures/tables, 50-100 key references): state-of-the-art overviews of hot topics and developments, often commissioned. Concise reviews, invited reviews, statistical reviews and meta-analysis should follow the same rules for reviews.
  • Hypothesis/Ideas: manuscripts (8 journal pages or less) that present an original hypothesis or an innovative idea. The article should set out a clearly identified hypothesis that can be supported by appropriate references justifying the validity of the hypothesis. The article should propose what experimental work might test the hypothesis, but should not contain new data of an experimental nature unless essential.
  • Methodologies/Technical Notes/Protocols: Original articles (≤8 journal pages describing experimental work using a new methodology which provides a detailed account of the protocol and results without in-depth speculation on the implications of the findings. The new protocol should not be followed up in the same communication with what amounts to a full research paper using it.
  • Commentaries/Perspectives/Opinions: Short notes or letters (no more than 4 journal pages in length) commentating on papers published in the Journal. Perspectives or opinions can also be presented within the limit of 4 journals pages giving a viewpoint on the already being applied methodologies, protocols, data or highlighting the critical issues in cancer research.
  • Editorials/Letters: While guest editorials are preponderantly solicited, persons interested in contributing editorials from the editorial or reviewer board members, and letters from the authors or readers are encouraged to contact the Editor.

2. Editorial policies

2.1 Peer review policy

The Cancer Press operates a conventional single-blind reviewing policy in which the reviewer’s names are always concealed from the submitting author. All manuscripts are reviewed initially by the Editors and only those papers that meet the scientific and editorial standards of the journal, and fit within the aims and scope of the journal, will be sent for outside review. Cancer Press has its own editorial and reviewer board for pre- and final evaluation of manuscript regarding the technical and scientific quality, respectively.

Authors are requested to suggest the names, affiliations and contact information of up to four individuals who may be suitable to serve as referees, but the Editors are under no obligation to use all or any of these individuals as reviewers.

Peer Review Process: We endeavor to obtain at least 2 referee’s reports. All manuscripts are reviewed as rapidly as possible, and an editorial decision is generally reached within 3-4 weeks of submission.

As part of the submission process you will be asked to provide the names of 2-4 peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below: 

  • The reviewer should have no prior knowledge of your submission
  • The reviewer should not have recently collaborated with any of the authors
  • Reviewer nominees from the same institution as any of the authors are not permitted

Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.

 2.2 Authorship

Cancer Press endorses the Vancouver Guidelines on authorship as defined in the International Committee of Medical Journal Editors' (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals, namely that entitlement to authorship should be based on all of the following criteria: (1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it for important intellectual content; (3) final approval of the version to be published. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements.

Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

 2.3 Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

2.3.1 Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance-including the individual’s name, company and level of input - and identify the entity that paid for this assistance.

It is not necessary to disclose use of language polishing services.

Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

2.4 Funding

Cell Therapy & Regenerative Medicine requires all authors to acknowledge their funding in the form of a sentence with the full name of the funding agency followed by the grant number in square brackets.

2.5 Declaration of conflicting interests

It is the policy of Cancer Press and iMaQ Publishing Group (intl.)  to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

For guidance on conflict of interest statements, please see the ICMJE recommendations here

2.6 Experimental and publishing ethics

2.6.1 Experimental ethics

Caner Press journal asks authors to certify that all animals utilized in their research were cared for according to the policies and principles established by the Animal Welfare Act and the NIH Guide for Care and Use of Laboratory Animals.  Experiments with animals should be performed in accordance with the legal requirements of the relevant local or national authority. Procedures should be such that experimental animals do not suffer unnecessarily. The text of papers should include details of the strain or stock of animal used, experimental procedures, and of anesthetics used. It is recommended that authors refer to the 'ARRIVE' Guidelines on the reporting of animal research.

Papers describing any experimental work with humans should include a statement that the research has been carried out in accordance with the Declaration of Helsinki (2008) of the World Medical Association, that the Ethical Committee of the Institution in which the work was performed has approved it, and that the subjects have given written informed consent to the work.

The Editorial Board will not accept papers where the ethical aspects are, in the Board's opinion, open to doubt.

iMaQ publishing group (International) endorses the guidelines published by COPE (Committee on Publication Ethics) and will always investigate fully any matters of apparent misconduct that it becomes aware of.

Cancer Press as a part of iMaQ publishing group follows the guidelines published by COPE in respect of the retraction of articles.

2.6.2 Plagiarism

We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors.

We take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice.

Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

 

 

2.7 Open access publication

Cancer Press is a peer-reviewed, open access journal, which means that all published articles are made freely available online without a subscription, and authors retain the copyright of their work.

Article Processing Charges (APCs): All articles submitted to The Cancer Press will be charged 100 USD per article (equal amount for regional countries like India, Pakistan, Iran, Turkey etc) which should be deposited at the time of manuscript submission.

Note: "The Cancer Press" (Journal) is not charging any kind of fee for the year of 2016. All submitted manuscripts will be processed free of cost.

  3. Preparing your manuscript

3.1 Format of manuscript and Order of contents

Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

Your manuscript should be written in clear, concise, and grammatically correct International English; manuscripts that are inadequately prepared in the required format of the journal will be declined, since it is not feasible for the Editors to undertake extensive revision or rewriting of manuscripts.

ü  Title page: this should contain the following:

  • article title
  • name(s) of author(s) (with first or second given name spelled out in full)
  • author affiliation(s)
  • Short running title (abbreviated form of title): no more than 65 characters including spaces and punctuations.
  • name and complete mailing address (including telephone and fax numbers and email address) of the person to whom correspondence should be sent
  • up to eight key words (in alphabetical order), of which at least three do not appear in the title of the paper list of abbreviations used (no need to list standard abbreviations such as DNA, RNA etc; use SI units wherever possible)

The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting here for guidelines on How to Help Readers Find Your Article Online.

ü  Abstract (maximum 250 words; no subheadings, not included in section numbering): this must be concise and factual, and able to stand alone.

ü  Subdivision: divide your paper into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, etc).

  1. Introduction: the objectives of the work should be stated and an adequate background provided; avoid a detailed literature survey or a summary of the results.
  2. Materials and methods: provide sufficient detail to allow the work to be reproduced; methods already published should be indicated by a reference and only relevant modifications described
  3. Results: this section should be clear and concise, and may be combined with the Discussion section if appropriate
  4. Discussion: this section should explore the significance of the results, not repeat them; extensive citations and discussion of published literature should be avoided
  5. Conclusions: the main conclusions may be presented in this short section, which may stand alone or form a subsection of the Discussion section

ü  Acknowledgements: list those individuals who provided assistance during the research or provided help with the writing of the article

ü  Funding: in the form of a sentence with the full name of the funding agency followed by the grant number in square brackets

ü  Declaration of conflicting interests:

ü  References should be followed as explained in Section 3.4 (iMaQ Reference style).

ü  Tables with their titles.

ü  Figure Legends

ü  Figures

For Research article please see this Sample to comply with the Journal Style.

For Review article please see this Sample

Please be sure to submit your illustrations and tables as separate files the system will automatically create a pdf file of your paper for the reviewers.

3.2 Artwork, figures and other graphics

For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit Manuscript Submission Guidelines

The Cancer Press will be published in an online-only format. Thus, Figures supplied in colour will appear in colour online.

3.3 Supplementary material

The Cacner Press  is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article.  For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page. 

3.4 Reference style

The Cancer Press adheres to the iMaQ reference style. Click here to review the guidelines and samples on iMaQ reference style to ensure your manuscript conforms to this reference style. If you use EndNote to manage references, you can download the iMaQ reference style output file here and if you use Mendeley you can download the iMaQ reference style output file here

3.5 English language editing services

Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using iMaQ Language Services.

4. Submitting your manuscript

4.1 How to submit your manuscript

The Cancer Press  is hosted by DiscoverSys Inc., a web based online submission and peer review system powered by eJournals. Visit http://thecancerpress.com/index.php/cp/author/submit/1 to login and submit your article online.

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.

4.2 Corresponding author contact details

Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

5. On acceptance and publication

5.1 Access to your published article

The iMaQ production department will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors will provide with online access to their final article.

5.2 Online First publication

Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication.

6. Further information

Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Cancer Press editorial office as follows:

Ms. Narjes Khalilipour at the following email address: 
manager@thecancerpress.com